FDA Inspection
Nesher Pharmaceuticals (USA) LLCNesher Pharmaceuticals (USA) LLC – FDA Inspection, Feb 3, 2017
Record Details
This FDA Inspection record concerns Nesher Pharmaceuticals (USA) LLC, with an inspection on February 3, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b0dbdee3-b0e2-4766-a2a3-be6d46fe27b0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1002473
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Nesher Pharmaceuticals (USA) LLC
10| Date | Classification | Office | Project area |
|---|---|---|---|
| August 12, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 31, 2019 | OAI | Kansas City District Office | Generic Drug Evaluation |
| May 31, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 18, 2018 | Not classified | Kansas City District Office | |
| January 11, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Nesher Pharmaceuticals (USA) LLC
- FDA Inspection 1151199 - 2021-08-12
- FDA Inspection 1098358 - 2019-07-31
- FDA Inspection 1092585 - 2019-05-31
- FDA Inspection 1059731 - 2018-07-18
- FDA Inspection 1040785 - 2018-01-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.